Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Sarobe

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cancer Immunology Research|December 12, 2024
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune ResponseYaiza Senent, Ana Remírez, David Repáraz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1Lucía Gil-Guerrero, Javier Dotor, Inge Louise Huibregtse, et al.
Oncoimmunology|March 19, 2026
Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapyBelén Aparicio, Leyre Silva, Marta Ruiz, et al.
Immunological Investigations|October 17, 2023
Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular CarcinomaFarsaneh Sadeghlar, Julia Seelemann, Annabelle Vogt, et al.
Journal for Immunotherapy of Cancer|February 23, 2022
Neoantigens as potential vaccines in hepatocellular carcinomaDavid Repáraz, Marta Ruiz, Diana Llopiz, et al.
British Journal of Cancer|January 6, 2021
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1<sup>+</sup> tumour-infiltrating lymphocytesDiego Salas-Benito, Enrique Conde, Ibon Tamayo-Uria, et al.
Hepatology (Baltimore, Md.)|November 27, 2024
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in miceEnric Vercher, Ángela Covo-Vergara, Enrique Conde, et al.
Blood|February 3, 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapyMarcos Garcia-Lacarte, Sara C Grijalba, Javier Melchor Sánchez, et al.
Cell Reports. Medicine|April 2, 2026
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinomaElena Adan-Villaescusa, Borja Castello-Uribe, Iker Uriarte, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancer Immunology Research|December 12, 2024
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune ResponseYaiza Senent, Ana Remírez, David Repáraz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1Lucía Gil-Guerrero, Javier Dotor, Inge Louise Huibregtse, et al.
Oncoimmunology|March 19, 2026
Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapyBelén Aparicio, Leyre Silva, Marta Ruiz, et al.
Immunological Investigations|October 17, 2023
Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular CarcinomaFarsaneh Sadeghlar, Julia Seelemann, Annabelle Vogt, et al.
Journal for Immunotherapy of Cancer|February 23, 2022
Neoantigens as potential vaccines in hepatocellular carcinomaDavid Repáraz, Marta Ruiz, Diana Llopiz, et al.
British Journal of Cancer|January 6, 2021
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1<sup>+</sup> tumour-infiltrating lymphocytesDiego Salas-Benito, Enrique Conde, Ibon Tamayo-Uria, et al.
Hepatology (Baltimore, Md.)|November 27, 2024
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in miceEnric Vercher, Ángela Covo-Vergara, Enrique Conde, et al.
Blood|February 3, 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapyMarcos Garcia-Lacarte, Sara C Grijalba, Javier Melchor Sánchez, et al.
Cell Reports. Medicine|April 2, 2026
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinomaElena Adan-Villaescusa, Borja Castello-Uribe, Iker Uriarte, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Pageof 9